Published in Cancer Imaging on May 21, 2012
Diffuse Large B-Cell Lymphoma Presenting with Bilateral Renal Masses and Hematuria: A Case Report. Turk J Haematol (2016) 0.75
Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology (1998) 3.81
Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet (1994) 3.73
The natural history of renal angiomyolipoma. J Urol (1993) 3.41
Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging. Urology (2006) 2.59
Renal cystic diseases: a review. Adv Anat Pathol (2006) 2.27
Extranodal Hodgkin disease: spectrum of disease. Radiographics (2001) 1.99
Primary renal lymphoma does exist: case report and review of the literature. J Nephrol (2001) 1.63
Secondary carcinomas of the kidney. J Urol (1975) 1.59
Imaging of renal lymphoma: patterns of disease with pathologic correlation. Radiographics (2006) 1.52
Tuberous sclerosis complex: renal imaging findings. Radiology (2002) 1.51
EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma. Eur Urol (2004) 1.47
Renal metastases: clinicopathologic and radiologic correlation. Radiology (1987) 1.39
Hereditary renal cancers. Radiology (2003) 1.31
CT evaluation of renovascular disease. Radiographics (2000) 1.19
CT of renal lymphoma in children. AJR Am J Roentgenol (2003) 1.17
Pediatric renal leukemia: spectrum of CT imaging findings. Pediatr Radiol (2008) 1.13
Autosomal dominant polycystic kidney disease: emerging concepts of pathogenesis and new treatments. Cleve Clin J Med (2009) 1.10
Primary renal lymphoma: report of four cases. Onkologie (2009) 1.01
Computed tomography of renal lymphoma with ultrasound correlation. J Comput Assist Tomogr (1983) 0.99
Radiological parameters of bleeding renal angiomyolipoma. Scand J Urol Nephrol (1996) 0.93
Metastatic tumors to the kidney. A postmortem, radiologic and clinical investigation. Acta Radiol Diagn (Stockh) (1982) 0.89
Autosomal dominant polycystic kidney disease-type 2. Ultrasound, genetic and clinical correlations. Nephrol Dial Transplant (2000) 0.82
Extra-medullary plasmacytoma of the kidney. Br J Radiol (1984) 0.81
Renal sonography in American Burkitt lymphoma. AJR Am J Roentgenol (1986) 0.81
CT imaging of mass-like renal lesions in children. Pediatr Radiol (2007) 0.78
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med (2006) 6.18
Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. Cancer Cell (2006) 4.13
Regulation of tumor angiogenesis by EZH2. Cancer Cell (2010) 3.10
A vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug, SF1126, with antitumor and antiangiogenic activity. Cancer Res (2008) 2.30
Pharmacodynamic markers of perifosine efficacy. Clin Cancer Res (2007) 2.28
PBI-05204, a supercritical CO₂ extract of Nerium oleander, inhibits growth of human pancreatic cancer via targeting the PI3K/mTOR pathway. Invest New Drugs (2014) 2.04
Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms. J Clin Invest (2008) 1.87
Dual inhibition of tumor energy pathway by 2-deoxyglucose and metformin is effective against a broad spectrum of preclinical cancer models. Mol Cancer Ther (2011) 1.81
Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer. Lancet Oncol (2011) 1.65
Imaging in the diagnosis, staging, and follow-up of colorectal cancer. AJR Am J Roentgenol (2002) 1.47
Renal cell carcinoma: diagnosis, staging, and surveillance. AJR Am J Roentgenol (2008) 1.35
Hyaluronic acid-paclitaxel: antitumor efficacy against CD44(+) human ovarian carcinoma xenografts. Neoplasia (2007) 1.29
Diffusion-weighted MRI in the detection of prostate cancer: meta-analysis. AJR Am J Roentgenol (2012) 1.28
The 3p21.3 tumor suppressor NPRL2 plays an important role in cisplatin-induced resistance in human non-small-cell lung cancer cells. Cancer Res (2006) 1.19
NY-ESO-1 DNA vaccine induces T-cell responses that are suppressed by regulatory T cells. Clin Cancer Res (2009) 1.14
Diagnosis, staging, and surveillance of pancreatic cancer. AJR Am J Roentgenol (2003) 1.12
Antitumor and antivascular effects of AVE8062 in ovarian carcinoma. Cancer Res (2007) 1.11
Evaluation of the patient with flank pain and possible ureteral calculus. Radiology (2003) 1.10
Imaging features of carcinoid tumors of the gastrointestinal tract. AJR Am J Roentgenol (2013) 1.10
Imaging features of fibrolamellar hepatocellular carcinoma. AJR Am J Roentgenol (2014) 1.06
Exogenous gene expression in tumors: noninvasive quantification with functional and anatomic imaging in a mouse model. Radiology (2005) 1.06
New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging. PLoS One (2009) 1.06
Imaging in the diagnosis, staging, treatment, and surveillance of hepatocellular carcinoma. AJR Am J Roentgenol (2003) 1.04
Imaging in oncology from the University of Texas M. D. Anderson Cancer Center: diagnosis, staging, and surveillance of prostate cancer. AJR Am J Roentgenol (2007) 1.03
Diagnosis, staging, and surveillance of cervical carcinoma. AJR Am J Roentgenol (2003) 1.03
Quality initiatives: CT radiation dose reduction: how to implement change without sacrificing diagnostic quality. Radiographics (2011) 0.99
Dynamic contrast-enhanced MRI for the detection of prostate cancer: meta-analysis. AJR Am J Roentgenol (2015) 0.97
Feasibility of multiple-mouse dynamic contrast-enhanced MRI. Magn Reson Med (2007) 0.95
Imaging long-term fate of intramyocardially implanted mesenchymal stem cells in a porcine myocardial infarction model. PLoS One (2011) 0.95
Diffusion weighted imaging in prostate cancer. Eur Radiol (2010) 0.95
Effect of transforming growth factor beta (TGF-β) receptor I kinase inhibitor on prostate cancer bone growth. Bone (2011) 0.93
Hepatic arterial embolization with doxorubicin-loaded superabsorbent polymer microspheres in a rabbit liver tumor model. Cardiovasc Intervent Radiol (2011) 0.91
Echo-planar imaging for MRI evaluation of intrathoracic tumors in murine models of lung cancer. J Magn Reson Imaging (2008) 0.90
Fast three-dimensional dual echo dixon technique improves fat suppression in breast MRI. J Magn Reson Imaging (2010) 0.90
Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancer. Gynecol Oncol (2012) 0.89
Signaling can be uncoupled from imaging of the somatostatin receptor type 2. Mol Imaging (2007) 0.88
Transformation of human mesenchymal cells and skin fibroblasts into hematopoietic cells. PLoS One (2011) 0.88
Multimodality imaging of common and uncommon peritoneal diseases: a review for radiologists. Abdom Imaging (2015) 0.87
Fast Dixon whole-body MRI for detecting distant cancer metastasis: a preliminary clinical study. J Magn Reson Imaging (2011) 0.86
Fast dixon-based multisequence and multiplanar MRI for whole-body detection of cancer metastases. J Magn Reson Imaging (2009) 0.86
In vivo functional and anatomic imaging for assessment of in vivo gene transfer. Radiology (2009) 0.85
Perfusion CT assessment of tissue hemodynamics following hepatic arterial infusion of increasing doses of angiotensin II in a rabbit liver tumor model. Radiology (2011) 0.83
Conspicuity of bone metastases on fast Dixon-based multisequence whole-body MRI: clinical utility per sequence. Magn Reson Imaging (2013) 0.82
Diagnosis, staging, and follow-up of esophageal cancer. AJR Am J Roentgenol (2003) 0.81
Follow-up of known carcinoid liver metastases: is respiratory-gated t(2) fast spin-echo enough? Neuroendocrinology (2011) 0.81
Imaging in oncology from the University of Texas M. D. Anderson Cancer Center. Imaging in the diagnosis, staging, and follow-up of cancer of the urinary bladder. AJR Am J Roentgenol (2003) 0.81
Impact of multislice CT on imaging of acute abdominal disease. Radiol Clin North Am (2003) 0.80
Visualization and quantification of intraperitoneal tumors by in vivo computed tomography using negative contrast enhancement strategy in a mouse model of ovarian cancer. Transl Oncol (2009) 0.79
Reproducibility and comparison of DCE-MRI and DCE-CT perfusion parameters in a rat tumor model. Technol Cancer Res Treat (2012) 0.79
Noninvasive assessment of gene transfer and expression by in vivo functional and morphologic imaging in a rabbit tumor model. PLoS One (2013) 0.79
Imaging acute complications in cancer patients: what should be evaluated in the emergency setting? Cancer Imaging (2014) 0.78
Quantification of mineralized bone response to prostate cancer by noninvasive in vivo microCT and non-destructive ex vivo microCT and DXA in a mouse model. PLoS One (2010) 0.78
Somatostatin receptor type 2-based reporter expression after plasmid-based in vivo gene delivery to non-small cell lung cancer. Mol Imaging (2013) 0.78
Quantitative and Qualitative Comparison of Single-Source Dual-Energy Computed Tomography and 120-kVp Computed Tomography for the Assessment of Pancreatic Ductal Adenocarcinoma. J Comput Assist Tomogr (2015) 0.77
Performance evaluation of iterative reconstruction algorithms for achieving CT radiation dose reduction - a phantom study. J Appl Clin Med Phys (2016) 0.77
Diagnostic approach to hereditary renal cell carcinoma. AJR Am J Roentgenol (2015) 0.76
Abdominal and pelvic complications of nonoperative oncologic therapy. Radiographics (2014) 0.76
Common and uncommon adult unilateral renal masses other than renal cell carcinoma. Cancer Imaging (2012) 0.76
Spectrum of imaging findings in the abdomen after radiotherapy. AJR Am J Roentgenol (2006) 0.76
Functionalized polymeric nanoparticles loaded with indocyanine green as theranostic materials for targeted molecular near infrared fluorescence imaging and photothermal destruction of ovarian cancer cells. Lasers Surg Med (2014) 0.76
Visualizing the prostate gland by MR imaging in young and old mice. PLoS One (2013) 0.75
"Computed tomography of the liver"--a commentary. AJR Am J Roentgenol (2006) 0.75
Staging, surveillance, and evaluation of response to therapy in renal cell carcinoma: role of MDCT. Abdom Imaging (2014) 0.75
Virus-resembling nano-structures for near infrared fluorescence imaging of ovarian cancer HER2 receptors. Nanotechnology (2015) 0.75
Biomimetic and bioinspired materials for applications in biophotonics. J Biomed Opt (2014) 0.75
Dose reduction in CT urography and vasculature phantom studies using model-based iterative reconstruction. J Appl Clin Med Phys (2016) 0.75
Current update on cytogenetics, taxonomy, diagnosis, and management of adrenocortical carcinoma: what radiologists should know. AJR Am J Roentgenol (2012) 0.75
Optical Characteristics and Tumor Imaging Capabilities of Near Infrared Dyes in Free and Nano-Encapsulated Formulations Comprised of Viral Capsids. ACS Appl Mater Interfaces (2017) 0.75